In vitro and in vivo suppression of GJB2 expression by RNA interference

Yukihide Maeda, Kunihiro Fukushima, Kazunori Nishizaki, Richard J H Smith

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2R75W expression by >70% of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.

Original languageEnglish
Pages (from-to)1641-1650
Number of pages10
JournalHuman Molecular Genetics
Volume14
Issue number12
DOIs
Publication statusPublished - Jun 15 2005

Fingerprint

RNA Interference
Hearing Loss
Alleles
Small Interfering RNA
Mutant Proteins
Genes
Cultured Cells
Connexin 26
In Vitro Techniques
Gene Expression
Mutation

ASJC Scopus subject areas

  • Genetics

Cite this

In vitro and in vivo suppression of GJB2 expression by RNA interference. / Maeda, Yukihide; Fukushima, Kunihiro; Nishizaki, Kazunori; Smith, Richard J H.

In: Human Molecular Genetics, Vol. 14, No. 12, 15.06.2005, p. 1641-1650.

Research output: Contribution to journalArticle

Maeda, Yukihide ; Fukushima, Kunihiro ; Nishizaki, Kazunori ; Smith, Richard J H. / In vitro and in vivo suppression of GJB2 expression by RNA interference. In: Human Molecular Genetics. 2005 ; Vol. 14, No. 12. pp. 1641-1650.
@article{b3de3471b011465d959c2c70a1a84867,
title = "In vitro and in vivo suppression of GJB2 expression by RNA interference",
abstract = "Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2R75W expression by >70{\%} of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.",
author = "Yukihide Maeda and Kunihiro Fukushima and Kazunori Nishizaki and Smith, {Richard J H}",
year = "2005",
month = "6",
day = "15",
doi = "10.1093/hmg/ddi172",
language = "English",
volume = "14",
pages = "1641--1650",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - In vitro and in vivo suppression of GJB2 expression by RNA interference

AU - Maeda, Yukihide

AU - Fukushima, Kunihiro

AU - Nishizaki, Kazunori

AU - Smith, Richard J H

PY - 2005/6/15

Y1 - 2005/6/15

N2 - Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2R75W expression by >70% of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.

AB - Mutations in GJB2 (gap junction protein, beta-2) are the major cause of autosomal recessive non-syndromic hearing loss. A few allele variants of this gene also cause autosomal dominant non-syndromic hearing loss as a dominant-negative consequence of expression of the mutant protein. Allele-specific gene suppression by RNA interference (RNAi) is a potentially attractive strategy to prevent hearing loss caused by this mechanism. In this proof-of-principle study, we identified a potent GJB2-targeting short interfering RNA (siRNA) to post-transcriptionally silence the expression of the R75W allele variant of GJB2 in cultured mammalian cells. In a mouse model, this siRNA duplex selectively suppressed GJB2R75W expression by >70% of control levels, thereby preventing hearing loss. The level of endogenous murine Gjb2 expression was not affected. Our data show that RNAi can be used with specificity and efficiency in vivo to protect against hearing loss caused as a dominant-negative consequence of mutant gene expression.

UR - http://www.scopus.com/inward/record.url?scp=21244488153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244488153&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddi172

DO - 10.1093/hmg/ddi172

M3 - Article

C2 - 15857852

AN - SCOPUS:21244488153

VL - 14

SP - 1641

EP - 1650

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 12

ER -